Clinical Trial Update: A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial evaluating FK949E for major depressive episodes in bipolar disorder has completed Phase 2 and Phase 3, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• FK949E

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Bipolar Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-02-08